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Abstract
Background: The prevalence of allergy in athletes is increasing, and its risk varies across sports. The risk is
dependent mainly on the ventilation rate and environmental factors; however, the prevalence of allergy in elite
runners remains unknown. Therefore, the aim of this study was to screen allergy symptoms in elite marathon
runners by using a validated questionnaire for screening allergy in athletes.
Methods: Two hundred and one elite marathoners, who participated in the most competitive Brazilian marathons
and half-marathons during 2011, were invited to complete a validated self-report Allergy Questionnaire for Athletes
(AQUA©), with additional questions pertaining to training history, such as running experience, running distance per
week and their best race time in marathon or half-marathon events.
Results: Sixty percent of the assessed athletes reported allergy symptoms as defined by a positive AQUA outcome
(score [greater than or equal to] 5). No significant differences (p > 0.05) between groups (AQUA + and AQUA-) were
observed for gender, age, running experience, weekly training volume and best performance time in the half-marathon
and marathon. The most frequently reported symptoms were related to the respiratory tract and physical effort.
Conclusions: This study demonstrates that AQUA© can be used to predict allergy in elite marathon runners. In addition,
these athletes have a higher prevalence of allergy symptoms to elite athletes from other sports.
Introduction
Allergy disease is a common condition which affects more
than one out of five individuals, and is characterized by an
abnormal response of the immune system to harmless
substances such as pollen, dust, animal dander, food, drug
and venom [1]. The prevalence of allergic diseases in elite
athletes has been reported to range from 10% to 74%
[2-4], and this wide variability appears to depend on the
diagnostic method used to quantify allergic symptoms, the
environmental conditions, an athletes’ training history (i.e.
intensity, frequency and volume) and sport modality [5-7].
Despite studies showing high prevalence rates of allergic
symptoms in athletes [8,9], no specific diagnostic protocol
has yet been established as part of a routine clinical as-
sessment in this cohort [3,10,11]. Bonini and colleagues
have developed the Allergy Questionnaire for Athletes
(AQUA©), which has been validated, and has a high pre-
dictive value, for identifying athletes with allergic airway
disease [6]. Allergy screening utilizing the AQUA© ques-
tionnaire has been previously used in soccer players [6],
Olympic athletes [12], and recreational runners [7].
It has been shown that high-performance athletes, espe-
cially those who take part in winter or high-ventilation
sports have a higher prevalence of allergic symptoms
[5,13,14], and are therefore more susceptible to allergic
illnesses due to an association between the repeated
physical stress of intense training, and frequent exposure
to unfavorable environmental conditions, such as high
levels of aeroallergens, pollution, pollen, and changes in
air temperature (i.e., dry and cold air) [2,15].
Long distance running (i.e. marathon) is an endurance
sport that requires an extensive amount of training, es-
pecially at the elite level, and consists of a high running
volume, in conjunction with high-intensity continuous
running and short bursts of high-intensity efforts. As such
there is evidence to suggest that high-volume and high-
intensity training may cause overtraining leading to im-
munosuppression and increased susceptibility to allergic
diseases [16].
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To the best of our knowledge, there is no data regard-
ing the prevalence of allergy symptoms in elite marathon
runners in Brazil. Therefore, the aim of this study was to
screen for allergic symptoms in elite marathon runners
using the AQUA© questionnaire.
Methods
Subjects
Two hundred and thirty elite marathon runners were in-
vited to take part in this cross sectional study. The ath-
letes were recruited from elite Brazilian marathon and
half-marathon runners who competed during the 2011.
The inclusion criteria were: age between 20 and 50 years,
and completion of a marathon in the past 18 months under
a time of 2 hr:35 min:00 sec for men and 3 hr:00 min:00 sec
for women, or a half-marathon time below 1 hr:23min:00 sec
for men and 1 hr:35 min:00 sec for women; this criteria
was adopted to ensure that we recruited completive endur-
ance runners. All of the athletes who agreed to participate
in the present study gave written informed consent prior to
enrollment in the study. The clinical protocol was approved
by the local human research ethics committee.
Study design
Allergy symptoms were evaluated by the AQUA© [6], a
validated questionnaire specifically developed for athletes,
which has been translated into 9 European languages, in-
cluding Portuguese. The permission to use the AQUA©
was granted by the copyright holders. The AQUA© has
previously been validated in 128 professional football
players [6], in conjunction with the diagnosis of allergy
using salivary immunoglobulin E determination and skin
prick testing, and detailed allergy history. A mean total
AQUA© score of greater than five has the best positive
predictive value for allergy (0.94), with a sensitivity of
58.3% and specificity of 97.1% [6]. The AQUA© consists of
25 items regarding allergic symptoms, family history of
allergy, suspicion of allergy, and the use of allergy medi-
cines. In the present study, questions 4 to 16 (except
number 14) received a score, and the sum of these ques-
tions was used to classify AQUA + athletes (presenting a
score ≥5), and AQUA- athletes (presenting a score <5),
as previously described [6]. Athletes were asked add-
itional questions about running experience, running dis-
tance per week, and their completive performance in
marathon and half-marathon events.
Data analysis
The data were analyzed using the Sigma Stat 3.5 statistical
package (Chicago, IL). The Kolmogorov-Smirnov test was
used to verify the normality of the data, and Levene’s test
was used to test for homogeneity of variance between
groups. The Student’s t-test and the Chi-squared test were
used to compare continuous and categorical data between
groups (AQUA+ and AQUA- athletes), and difference be-
tween genders. The data are expressed as the median
(non-parametric) or mean (parametric) with a 95% confi-
dence interval (95% CI). The level of significance was set
at p ≤ 0.05.
Results
Twenty-nine out of 230 invited athletes declined to par-
ticipate in the study. The average age was 34 years old (22
to 49 years, 95% CI), with no significant difference being
observed between males (22 to 50, 95% CI) and females
(22 to 48, 95% CI) for average age. The athletes training
history, and racing experience and completive perform-
ance are shown in Table 1. The mean total AQUA© score
for the AQUA+ athletes was 12.5 ± 6.3 (range, 5–27).
There was no significant difference between groups
(p > 0.05) (AQUA + vs. AQUA-) in terms of gender, age,
running experience, weekly training volume, and best
performance time for the half-marathon and marathon
(Table 2). Of the 201 athletes analyzed, 122 of the athletes
(60.7%) presented an AQUA+ score ≥5), while 79 of the
athletes (39.3%) presented an AQUA- score <5.
Among the AQUA + athletes, 33 (25%) athletes re-
ported having only one allergic symptom, while 36 (30%)
had two, and 55 (45%) had three or more. Fifty-six (46%) of
the AQUA+ athletes reported having physician-diagnosed
allergy, 74 (60.7%) were suspected of suffering from allergy,
and 46 (37.7%) reported using, or had used, anti-allergy
drugs. The proportion of positive answers for the most fre-
quent questions is shown in Figure 1.
Discussion
To our knowledge the present study is the first to show
that elite marathon runners have a high prevalence of al-
lergic symptoms independent of gender, age, quantity of
training and performance times. Based on the data from
the present study, we suggest that an allergy screening
Table 1 Characteristic of athletes’ training, experience
and performance
Characteristics All athletes Male Female
(n = 201) (n = 165) (n = 36)
Training sessions (n/week) 6.7 (6–7) 6.7 (6–7) 6.8 (6–7)
Running distance
(km/week)
180 (140–220) 180 (150–220) 160 (120–217)
Running experience
(years)
11 (4–30) 11 (3–30) 11.5 (4–26)
Performance time in
21 km (min)
70 (62–87) 68 (62–80) 79 (73–91)
Performance time in
42 km (min)
148 (132–170) 143 (132–155) 160 (137–176)
Legend: data are presented as mean and 95% confidence interval (in
parenthesis); min =minutes, km = kilometers.
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test should be included as part of the clinical assessment
of endurance and high-level athletes.
We found that 60.7% of the subjects presented with
allergy symptoms as defined by a positive AQUA© ques-
tionnaire score. In the validation study of the AQUA©
questionnaire, Bonini et al. assessed 128 professional soccer
players [6] and observed an allergy prevalence of 32%,
approximately half the rate observed in the present
study. The discrepancy in the prevalence rate for allergy
between our study and the study of Bonini et al. [6] study
may be due the fact that elite marathon runners maintain
higher ventilation rates for a longer periods of time, and
this inhale greater amounts of allergens and airway irri-
tants compared to soccer players, who experience short
bursts of high-intensity exercise.
In the present study the majority of the reported symp-
toms were related to the upper respiratory tract, with
exercise-induced bronchoconstriction (EIB) being the
most prevalent reported symptom. Thus, 62% of the ath-
letes considered allergic (AQUA+) claimed shortness of
breath, cough and/or itchy throat during or following exer-
cise (AQUA© question 13). The prevalence of EIB symp-
toms was higher than those observed in soccer players and
recreational runners (11.7% and 32%, respectively) [6,7],
and was even higher than in a study previously performed
by our group that assessed the prevalence of EIB, using
eucapnic voluntary hyperventilation (EVH), in elite long
distance runners [17]. However, the lack of an objective as-
sessment, such as EVH, may have influenced the higher
prevalence of allergic symptoms that were observed in the
present study compared to our previous study [17].
It should be noted that the AQUA© was previously
validated against skin tests and has a high specificity
(97.1%) but a low sensitivity (58.3%) [6]; it is quite pos-
sible that AQUA + group included subjects with respira-
tory allergy and other “allergic” symptoms, and that not
all AQUA + subjects have necessarily to be skin test
positive. We also observed that 56.6% of our athletes re-
ported allergic rhinitis, which was the second most
prevalent respiratory symptom. The prevalence of rhin-
itis in our population seems relatively high, as it is more
than the levels observed in German elite athletes [11].
There are three possible explanations for the higher
prevalence rate of respiratory symptoms observed in the
elite marathon runners in the present study compared to
other athletes [11]: i) previous studies [6,11] have included
athletes from low- to moderate exercise intensity sports,
and thus less likely to trigger allergic symptoms ii) high
Table 2 Anthropometric and training data between
AQUA + and AQUA- athletes
AQUA+ AQUA- P = value
(n = 122) (n = 79)
Gender (F/M) 26/96 10/69 NS
Age (years) 33 (22.0-48.4) 34 (23.4-49.0) NS
Running experience
(years)
12.0 (4.0-28.2) 10.0 (3.0-29.5) NS
Running distance
(km/week)
180.0 (140.0-220.0) 180.0 (140.0-234.0) NS
Performance time in
21 km (min)
70.0 (63.0-88.0) 70.0 (62.9-84.0) NS
Performance time in
42 km (min)
149 (132–168) 149 (134–168) NS
Legend: data are presented as mean and 95% confidence interval (in parenthesis),
except for gender expressed in absolute number. F = female, M =male,
min =minutes, km/week = kilometers per week; NS = non-significant.
Figure 1 Frequency of the most reported AQUA© questions in athletes with AQUA+ score.
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performance marathon runners shift from nasal to mouth
breathing as a consequence of high-intensity training,
and this shift induces airway drying and cooling, and
contributes to airway epithelial damage [18,19]; and iii)
the physical demands of elite marathon runners may
outweigh the body’s ability to fully recover between training
sessions and competitions, reducing the athletes immuno-
logical response and predisposing them to upper airway
infections [20].
Environmental factors may also aggravate the effect of
heavy training on the airways of athletes [21]. For instance,
there are many environmental conditions that are sport
specific and can induce adverse effects on the respiratory
system, such as pollen exposure in athletes who train out-
doors, cold air in winter athletes [21,22], fine particles in
ice rinks [23] and chlorine exposure in swimmers [24]. In
our study, we compared the prevalence of allergy between
elite marathon runners living in metropolitan and rural
areas, and did not observe any difference between these
two environments (data not shown). Moreover, in our
study, environmental conditions do not seem to explain
the high prevalence of allergy; however, since we did not
perform skin tests, it is possible that environmental factors
may be more relevant in subjects with symptoms, but with
negative skin tests (for instance in EIB in non-allergic sub-
jects). Thus, further studies are required to investigate
whether environmental conditions affect the prevalence of
allergy in elite marathon runners.
A limitation of this study was that we did not assess
blood levels of immunoglobulin E (IgE) to quantify allergy.
However, it seemed unnecessary because the AQUA©
questionnaire has been previously validated based on its
association with IgE levels, and demonstrating high speci-
ficity [6]. Moreover, according to our previous experience
with elite runners [17], blood collection is not well ac-
cepted either by athletes or by their coaches due to pos-
sible doping concerns.
Conclusion
This study demonstrates that AQUA© can be used to pre-
dict allergy in elite marathon runners. In addition, these
athletes have a higher prevalence of allergy symptoms to
elite athletes from other sports. We also suggest that the
AQUA© may be a useful tool in the routine examination
to identify athletes with allergy symptoms, in conjunction
with accurate allergy testing and functional assessment.
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